1. Home
  2. IPO
  • Entero Healthcare Solutions Ltd Ipo
91925
Off
Entero Healthcare IPO

Entero Healthcare Solutions IPO

  • Status: Closed
  • RHP:
  • ₹ 13,145 / 11 shares

    Minimum Investment

IPO Listing Details

  • Listing Date

    16 Feb 2024

  • Listing Price

    ₹1,245.00

  • Listing Change

    -1.03%

  • Last Traded Price

    ₹1,463.70

IPO Details

  • Open Date

    09 Feb 2024

  • Close Date

    13 Feb 2024

  • IPO Price Range

    ₹ 1195 to ₹ 1258

  • IPO Size

    ₹ 1,600 Cr

  • Listing Exchange

    BSE, NSE

  • Listing Date

    16 Feb 2024

With just a few clicks, Invest in IPOs!

+91
Resend OTP

By proceeding, you agree to all T&C*

hero_form
Timeline Subscription Status Objective Financials SWOT FAQ Contacts

IPO Timeline

Entero Healthcare Solutions IPO Subscription Status

Last Updated: 15 February 2024 5:36 PM by 5Paisa

Entero Healthcare Solutions IPO is set to open from 9th February to 13th February 2024. The company distributes healthcare products. The IPO includes a fresh issue of 7,949,125 shares worth ₹1000.00 cr. and an Offer-for-Sale (OFS) of 4,769,475 shares worth ₹600.00 cr. The total IPO size is ₹1600.00 cr. The share allotment date is 14th February 2024, and the IPO will be listed on 16th February 2024 on the stock exchanges. The price band is set at ₹1195 to ₹1258 and the lot size is 11 shares.   

ICICI Securities Limited, Dam Capital Advisors Limited, Jefferies India Private Limited, Jm Financial Limited and SBI Capital Markets Limited are the book-running lead managers for this IPO, while Link Intime India Private Limited is the registrar. 

Objectives of Entero Healthcare Solutions IPO:

    • To repay or prepay in full or part the borrowings obtained by the company.
    • To fund working capital requirements.
    • To fund inorganic growth initiatives via acquisitions.
    • General corporate purposes.

Entero Healthcare Solutions IPO Video:

 

Established in 2018, Entero Healthcare Solutions distributes healthcare products and in terms of revenues ranks among the top three distributors in India as of FY22. The company operates as a technology-driven and integrated healthcare products distribution platform. 

As of March 2023,  Entero Healthcare Solutions had 73 distribution warehouses in 37 cities in 19 Indian states. It also had a customer base of 81,400 pharmacies and 3,400 hospitals in 495 districts of India for the same period. The company had supply relations with 1900 healthcare product manufacturers and had a reach to more than 64500 SKUs.

Peer Comparison
    • Medplus Health Services Limited

For More Information:
Webstory on Entero Healthcare Solutions IPO

Profit and Loss

Balance Sheet

Particulars (in Rs. Crores) FY23 FY22 FY21
Revenue from operations 3300.20 2522.06 1779.73
EBITDA 64.00 24.43 21.54
PAT -11.10 -29.43 -15.35
Particulars (in Rs. Crores) FY23 FY22 FY21
Total Assets 1308.72 1125.98 833.78
Share Capital 4.11 3.85 0.10
Total Borrowings 711.06 562.76 346.72
Particulars (in Rs. Crores) FY23 FY22 FY21
Net cash generated from / (used in) operating activities -45.31 -35.26 -68.68
Net cash from / (used in) investing activities -48.59 -161.73 -30.86
Net cash flow from / (used in) financing activities 72.76 211.19 88.71
Net increase (decrease) in cash and cash equivalents -21.14 14.19 -10.84


Strengths

1. The company is expected to leverage market consolidation in the fragmented healthcare products distribution market.
2. The company is one of the largest and fastest-growing healthcare product distribution platforms in the country. 
3. It has a track record of inorganic expansion and increased geographic reach, revenues and scale.
4. The company runs a differentiated business model offering comprehensive and integrated commercial and supply chain solutions. 
5. It has a proprietary technology platform. 
6. Experienced Promoters and professional senior management team.

Risks

    1. The company has very high working capital requirements. 
    2. It has reported a loss in the past. 
    3. The business can be adversely impacted by competition and industry consolidation.
    4. Changes in prescription drug pricing could impact the business. 
    5. The company has reported negative cash flows.
    6. It is subject to operational and logistical risks.

Will You Apply for Entero Healthcare Solutions IPO?

Yes No Maybe

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91
Resend OTP

By proceeding, you agree to all T&C*

footer_form

FAQs

Entero Healthcare Solutions IPO opens from 9th February to 13th February 2024.

The IPO size of Entero Healthcare Solutions IPO is ₹1600.00 cr. 

To apply for Entero Healthcare Solutions IPO, follow the steps given below
    • Login to your 5paisa account and select the issue in the current IPO section    
    • Enter the number of lots and the price at which you wish to apply for the Entero Healthcare Solutions IPO.    
    • Enter your UPI ID and click on submit. With this, your bid will be placed with the exchange.    
You will receive a mandate notification to block funds in your UPI app.

The GMP value of every IPO changes daily. To view today's GMP of Entero Healthcare Solutions IPO visit https://www.5paisa.com/ipo/ipo-gmp

The price band of Entero Healthcare Solutions IPO is set at ₹1195 to ₹1258 per share.

The minimum lot size of Entero Healthcare Solutions IPO is 11 shares and the minimum investment required to apply for the IPO is ₹13,145.

The share allotment date of Entero Healthcare Solutions IPO is 14th February 2024.

The Entero Healthcare Solutions IPO will be listed on 16th February 2024.

ICICI Securities Limited, Dam Capital Advisors Limited, Jefferies India Private Limited, Jm Financial Limited and SBI Capital Markets Limited are the book-running lead managers for this IPO.

Entero Healthcare Solutions will use proceeds for:
    • To repay or prepay in full or part the borrowings obtained by the company.
    • To fund working capital requirements.
    • To fund inorganic growth initiatives via acquisitions.
    • General corporate purposes.